Drug common name | PILARALISIB |
INN | pilaralisib |
Description | Pilaralisib is a small molecule pharmaceutical. It is currently being investigated in clinical studies. It is known to target phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform, phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform, phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform, and phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform. |
Classification | Small molecule |
Drug class | phosphatidylinositol 3-kinase (PI3K) inhibitors |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | COc1ccc(Cl)c(Nc2nc3ccccc3nc2NS(=O)(=O)c2cccc(NC(=O)C(C)(C)N)c2)c1 |
PDB | — |
CAS-ID | 1033110-57-4 |
RxCUI | — |
ChEMBL ID | CHEMBL3360203 |
ChEBI ID | — |
PubChem CID | — |
DrugBank | — |
UNII ID | 60ES45KTMK (ChemIDplus, GSRS) |